van Hemel N M, Dijkman B, de Voogt W G, Beukema W P, Bosker H A, de Cock C C, Jordaens L J L M, van Gelder I C, van Gelder L M, van Mechelen R, Ruiter J H, Sedney M I, Slegers L C
Neth Heart J. 2004 Jan;12(1):18-22.
Today, new pacing algorithms and stimulation methods for the prevention and interruption of atrial tachyarrhythmias can be applied on patients who need bradycardia pacing for conventional reasons. In addition, biventricular pacing as additive treatment for patients with severe congestive heart failure due to ventricular systolic dysfunction and prolonged intraventricular conduction has shown to improve symptoms and reduce hospital admissions. These new pacing technologies and the optimising of the pacing programmes are complex, expensive and time-consuming. Based on many clinical studies the indications for these devices are beginning to emerge. To support the cardiologist's decision-making and to prevent waste of effort and resources, the 'ad hoc committee' has provided preliminary recommendations for implantable devices to treat atrial tachyarrhythmias and to extend the treatment of congestive heart failure respectively.
如今,用于预防和中断房性快速心律失常的新型起搏算法和刺激方法可应用于因传统原因需要进行心动过缓起搏的患者。此外,双心室起搏作为因心室收缩功能障碍和室内传导延长导致的严重充血性心力衰竭患者的附加治疗方法,已显示出可改善症状并减少住院次数。这些新型起搏技术以及起搏程序的优化复杂、昂贵且耗时。基于众多临床研究,这些设备的适应证正逐渐显现。为支持心脏病专家的决策并防止精力和资源的浪费,“特别委员会”已分别针对治疗房性快速心律失常的植入式设备以及扩大充血性心力衰竭的治疗提供了初步建议。